Summary

Middle East Lactate Monitoring Devices Market Summary

The Middle East lactate monitoring devices market size was estimated at USD 3.93 million in 2024 and is projected to reach USD 7.21 million by 2033, growing at a CAGR of 7.06% from 2025 to 2033. The increasing awareness of the benefits of monitoring lactate in sports & healthcare, the rise in the need for point-of-care tests, and the growing adoption of remote patient monitoring & telemedicine are significant factors contributing to market growth.

In addition, expanding use in surgical and post-operative monitoring is further anticipated to propel market growth. The market is gaining momentum as critical care improvements and emergency preparedness become national priorities. In Gulf Cooperation Council (GCC) countries like Saudi Arabia and the UAE, large hospitals in major cities invest in handheld and benchtop lactate analyzers for rapid sepsis screening and trauma care. In addition, interest in sports and fitness-driven lactate monitoring is emerging in the Middle East market. Elite training centers in Dubai, Abu Dhabi, and Doha are incorporating lactate threshold testing into athlete development programs, aligning with global standards.

Moreover, expanding sports performance programs and rising critical care demands propel market growth further. Saudi Arabia’s investment in athletic excellence through Vision 2030 has led to increased adoption of lactate analyzers by professional sports teams, fitness centers, and academic institutions focused on exercise physiology. This momentum aligns with broader health goals, where performance tracking and metabolic assessments are becoming core to sports science.

Furthermore, rising cases of sepsis, trauma, and cardiac complications have elevated the use of lactate testing in emergency departments and ICUs. Hospitals are integrating handheld and point-of-care lactate monitors to support rapid triage and treatment decisions. For instance, in January 2025, a multicentre study in Qatar reported an early-onset GBS sepsis incidence of 0.58 per 1,000 live births and a late-onset rate of 0.33 per 1,000. Based on 123,878 births, 113 cases were confirmed, with a 7% mortality rate and 11% of survivors facing severe neurodisability.

Moreover, in September 2023, the Qatar National Sepsis Program commemorated World Sepsis Day with a national symposium and hospital-wide education initiatives to raise awareness among healthcare professionals and the public. The campaign emphasized early recognition and intervention, particularly through implementing the Sepsis Six Care Bundle, which includes lactate measurement as a core component.

The market also benefits from a gradual uptake of innovative biosensors and wireless technologies that simplify lactate tracking across diverse settings. As local distributors partner with global manufacturers and regulatory clarity improves, the Middle East countries are expected to play a significant role in advancing the regional adoption of next-gen lactate monitoring solutions.

Middle East Lactate Monitoring Devices Market Report Segmentation

This report forecasts revenue growth at regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 - 2033. For this study, Grand View Research has segmented the Middle East lactate monitoring devices market report based on product, application, end use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Chargeable Lactate Meters
• Battery Operated Lactate Meters
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Sports
• Medical
• Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals and Clinics
• Sports Institutes
• Home Care
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• Middle East
o Saudi Arabia
o UAE
o Kuwait
o Qatar
o Oman

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Product Segment
1.2.2. Application Segment
1.2.3. End Use
1.3. Information analysis
1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
1.10.1. Objective 1
1.10.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
Chapter 3. Middle East Lactate Monitoring Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rising incidence of sepsis and critical illnesses
3.2.1.2. Growing use in sports and fitness performance
3.2.1.3. Advancements in point-of-care and wearable technologies
3.2.2. Market restraint analysis
3.2.2.1. Limited penetration in low-resource healthcare settings
3.2.2.2. Clinical reliance on broader blood gas panels
3.3. Middle East Lactate Monitoring Devices Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.3.2.4. Environmental Landscape
3.3.2.5. Legal Landscape
3.3.2.6. Social Landscape
Chapter 4. Middle East Lactate Monitoring Devices Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Middle East Lactate Monitoring Devices Market Product Movement Analysis
4.3. Middle East Lactate Monitoring Devices Market Size & Trend Analysis, by Product, 2021 - 2033 (USD Million)
4.4. Chargeable Lactate Meters
4.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
4.5. Battery Operated Lactate Meters
4.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 5. Middle East Lactate Monitoring Devices Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Middle East Lactate Monitoring Devices Market Application Movement Analysis
5.3. Middle East Lactate Monitoring Devices Market Size & Trend Analysis, by Application, 2021 - 2033 (USD Million)
5.4. Sports
5.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
5.5. Medical
5.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
5.6. Others
5.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 6. Middle East Lactate Monitoring Devices Market: End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Middle East Lactate Monitoring Devices Market End Use Movement Analysis
6.3. Middle East Lactate Monitoring Devices Market Size & Trend Analysis, by End Use, 2021 - 2033 (USD Million)
6.4. Hospitals & Clinics
6.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
6.5. Sports Institutes
6.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
6.6. Home Care
6.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
6.7. Others
6.7.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 7. Middle East Lactate Monitoring Devices Market: Regional Estimates & Trend Analysis
7.1. Country Market Share Analysis, 2024 & 2033
7.2. Country Market Dashboard
7.3. Market Size & Forecasts Trend Analysis, 2021 - 2033:
7.4. Middle East
7.4.1. Saudi Arabia
7.4.1.1. Key country dynamics
7.4.1.2. Regulatory framework
7.4.1.3. Competitive scenario
7.4.1.4. Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
7.4.2. UAE
7.4.2.1. Key country dynamics
7.4.2.2. Regulatory framework
7.4.2.3. Competitive scenario
7.4.2.4. UAE market estimates and forecasts, 2021 - 2033 (USD Million)
7.4.3. Kuwait
7.4.3.1. Key country dynamics
7.4.3.2. Regulatory framework
7.4.3.3. Competitive scenario
7.4.3.4. Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)
7.4.4. Qatar
7.4.4.1. Key country dynamics
7.4.4.2. Regulatory framework
7.4.4.3. Competitive scenario
7.4.4.4. Qatar market estimates and forecasts, 2021 - 2033 (USD Million)
7.4.5. Oman
7.4.5.1. Key country dynamics
7.4.5.2. Regulatory framework
7.4.5.3. Competitive scenario
7.4.5.4. Oman market estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company/Competition Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2024
8.4. Company Profiles/Listing
8.4.1. Nova Biomedical
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product benchmarking
8.4.1.4. Strategic initiatives
8.4.2. ARKRAY, Inc.
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product benchmarking
8.4.2.4. Strategic initiatives
8.4.3. EKF Diagnostics
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product benchmarking
8.4.3.4. Strategic initiatives
8.4.4. TECOM Analytical Systems
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product benchmarking
8.4.4.4. Strategic initiatives
8.4.5. Sensa Core Medical
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product benchmarking
8.4.5.4. Strategic initiatives
8.4.6. VivaCheck Biotech
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product benchmarking
8.4.6.4. Strategic initiatives
8.4.7. ApexBio
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product benchmarking
8.4.7.4. Strategic initiatives
8.4.8. TaiDoc Technology Corporation
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Product benchmarking
8.4.8.4. Strategic initiatives